TSA Agent Fakes Lymphoma for Five Years to Get Time Off

A former Transportation Security Administration (TSA) agent has been freed on bond after being caught having faked a diagnosis of lymphoma for five years.

According to federal court documents and reported by NBC News, Marc Bess Sr., 42, of Riverdale, Ga., not only faked cancer for five years, he also took advantage of more than a year's worth of sick leave that was donated by federal employees.

Under the Voluntary Leave Transfer Program, federal employees can donate unused sick leave to colleagues who need extra time off for serious health conditions.

He was caught when he continued to submit paperwork from a doctor who had died. This doctor never treated Mr. Bess, and Mr. Bess was never diagnosed with any cancer, although he used a variety of means to score time off, including saying he had surgery planned.

Mr. Bess began his scam in 2009 when he submitted documents to his supervisors indicating he had abdominal lymphoma, and that he would need weekly radiation treatment.

Bess "drafted the entire Verification of Treatment letter, including the false diagnosis of cancer, from a template on his home computer, and he forged [the doctor's] signature on the letter," according to the complaint.

In the five years of his scam, Bess accumulated 2,240 hours of paid leave donated by his fellow federal workers, the government said. That amounts to 280 days, or 56 five-day work weeks.

He is due in court May 11 for a plea hearing on charges of embezzlement and theft of public money.

Source: NBC

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap